Hints and tips:
Related Topics
...The 20-person start-up is working with molecular diagnostics company Cepheid to develop a test that can run on their machines, which are owned by many labs....
...Robert Matiru, Unitaid’s director of operations, cites the GeneXpert molecular test developed by Cepheid, a Californian biotech company....
...The medical conglomerate owns Cepheid, a company in California that makes molecular diagnostic tests and equipment....
...US rival Danaher paid 44 times earnings before interest, tax, depreciation and amortisation for Cepheid in 2016....
...Danaher will acquire all of Cepheid’s outstanding shares, paying $53 apiece. The deal gives Cepheid an enterprise value of $4bn, including debt....
...In tuberculosis, the introduction of tests — led by Cepheid’s GeneXpert molecular polymerase chain reaction system — has marked important progress....
...Hack wrote her thesis on Cepheids, members of a class of very luminous variable stars found to be crucial in measuring the distance between galaxies....
...A molecular test called GeneXpert MTB/RIF, endorsed by the World Health Organisation (WHO) in 2010 and developed by the non-profit Foundation for Innovative New Diagnostics in partnership with Cepheid, a...
International Edition